To evaluate predictors and their association with overall survival from the start of last-line chemotherapy until death, we explored models within PAN and GI groups based on baseline PS, albumin, CRP, and mGPS in a basic model (adjustments for age, sex, hospital size, and cancer diagnosis; Table 2, and Supplementary Table S1). This evidence concerns the gene CRP and polyarteritis nodosa.